Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Thomas

Showing results (41-50 of 243) with videos related to

Pageof 25
Sort By:
Presse Medicale (Paris, France : 1983)|March 12, 2014
[Psychotropic drugs in prison]Thomas Fovet, Ali Amad, Catherine Adins, et al.
Neurophysiologie Clinique = Clinical Neurophysiology|July 11, 2024
Atrial fibrillation radiofrequency ablation in a patient with vagus nerve stimulationJeanne Benoit, Fabien Squara, Véronique Bourg, et al.
The American Journal of Psychiatry|October 19, 2010
Cortical activations during auditory verbal hallucinations in schizophrenia: a coordinate-based meta-analysisRenaud Jardri, Alexandre Pouchet, Delphine Pins, et al.
Journal of Psychosomatic Obstetrics and Gynaecology|October 13, 2010
Pain as a confounding factor in postnatal depression screeningRenaud Jardri, Michel Maron, Pierre Delion, et al.
Neurology|January 15, 2003
Persistence of ictal activity after functional hemispherectomy in Rasmussen syndromePierre Thomas, Benjamin Zifkin, Gabriela Ghetâu, et al.
European Archives of Psychiatry and Clinical Neuroscience|October 22, 2015
The age-dependent plasticity highlights the conceptual interface between borderline personality disorder and PTSDAli Amad, Nicolas Ramoz, Pierre Thomas, et al.
Schizophrenia Research|April 4, 2006
Attention for movement production: Abnormal profiles in schizophreniaYvonne Nathalie Delevoye-Turrell, Pierre Thomas, Anne Giersch
Current Pharmaceutical Design|June 20, 2015
Borderline Personality Disorder and Oxytocin: Review of Clinical Trials and Future DirectionsAli Amad, Pierre Thomas, M Mercedes Perez-Rodriguez
Clinical Drug Investigation|February 21, 2012
Switching patients with stable schizophrenia or schizoaffective disorder from olanzapine to risperidone long-acting injectableFernanda Rosa, Andreas Schreiner, Pierre Thomas, et al.
Epileptic Disorders : International Epilepsy Journal with Videotape|April 30, 2014
Early add-on treatment vs alternative monotherapy in patients with partial epilepsyFranck Semah, Pierre Thomas, Safia Coulbaut, et al.
Pageof 25

Showing results (41-50 of 243) with videos related to

Sort By:
Pageof 25
Presse Medicale (Paris, France : 1983)|March 12, 2014
[Psychotropic drugs in prison]Thomas Fovet, Ali Amad, Catherine Adins, et al.
Neurophysiologie Clinique = Clinical Neurophysiology|July 11, 2024
Atrial fibrillation radiofrequency ablation in a patient with vagus nerve stimulationJeanne Benoit, Fabien Squara, Véronique Bourg, et al.
The American Journal of Psychiatry|October 19, 2010
Cortical activations during auditory verbal hallucinations in schizophrenia: a coordinate-based meta-analysisRenaud Jardri, Alexandre Pouchet, Delphine Pins, et al.
Journal of Psychosomatic Obstetrics and Gynaecology|October 13, 2010
Pain as a confounding factor in postnatal depression screeningRenaud Jardri, Michel Maron, Pierre Delion, et al.
Neurology|January 15, 2003
Persistence of ictal activity after functional hemispherectomy in Rasmussen syndromePierre Thomas, Benjamin Zifkin, Gabriela Ghetâu, et al.
European Archives of Psychiatry and Clinical Neuroscience|October 22, 2015
The age-dependent plasticity highlights the conceptual interface between borderline personality disorder and PTSDAli Amad, Nicolas Ramoz, Pierre Thomas, et al.
Schizophrenia Research|April 4, 2006
Attention for movement production: Abnormal profiles in schizophreniaYvonne Nathalie Delevoye-Turrell, Pierre Thomas, Anne Giersch
Current Pharmaceutical Design|June 20, 2015
Borderline Personality Disorder and Oxytocin: Review of Clinical Trials and Future DirectionsAli Amad, Pierre Thomas, M Mercedes Perez-Rodriguez
Clinical Drug Investigation|February 21, 2012
Switching patients with stable schizophrenia or schizoaffective disorder from olanzapine to risperidone long-acting injectableFernanda Rosa, Andreas Schreiner, Pierre Thomas, et al.
Epileptic Disorders : International Epilepsy Journal with Videotape|April 30, 2014
Early add-on treatment vs alternative monotherapy in patients with partial epilepsyFranck Semah, Pierre Thomas, Safia Coulbaut, et al.
Pageof 25